Revive Therapeutics Ltd C.RVV

Alternate Symbol(s): RVVTF

Healthcare Biotechnology

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).

CSE:RVV - Post by User

Revive Therapeutics Ltd > Top players RVV$$$

<< Previous

Bullboard Posts

Next >>

Comment by IceColdBeeron Dec 17, 2020 7:58am

143 Views

Post# 32126283

RE:RE:RE:Top players RVV$$$

Look at you go Playa! Aren't you glad you bought back in and will get to enjoy the ride?

Chrisxd5 wrote:
The Global Autoimmune Hepatitis Diagnosis and Treatment Market declare this Major Company Profiles are : AstraZeneca PLC, Biocon, Ltd., Organovo Holdings, Inc., AbbVie, Inc., Abbott Laboratories, Inc., Gilead Lifesciences, Inc., Pfizer, Inc., GlaxoSmithKline PLC, Upcyte Technologies GmbH, Novartis International AG, Inova Diagnostics, Inc., Principia Biopharma, Inc., Bio-Rad Laboratories, Inc., Revive Therapeutics, Ltd., Bayer AG, Cipla, Ltd., Bristol-Myers Squibb Co., Arihantanam Life Care Pvt Ltd.